Gabelli Funds LLC Acquires 24,816 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Gabelli Funds LLC raised its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 54.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 70,673 shares of the company’s stock after purchasing an additional 24,816 shares during the quarter. Gabelli Funds LLC’s holdings in Viemed Healthcare were worth $567,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in the stock. LPL Financial LLC boosted its holdings in Viemed Healthcare by 1.6% in the fourth quarter. LPL Financial LLC now owns 194,690 shares of the company’s stock worth $1,561,000 after purchasing an additional 3,000 shares during the last quarter. Martingale Asset Management L P grew its holdings in shares of Viemed Healthcare by 11.0% in the fourth quarter. Martingale Asset Management L P now owns 34,836 shares of the company’s stock worth $279,000 after acquiring an additional 3,451 shares during the period. Bard Associates Inc. increased its position in Viemed Healthcare by 1.3% during the fourth quarter. Bard Associates Inc. now owns 349,526 shares of the company’s stock valued at $2,803,000 after acquiring an additional 4,474 shares during the last quarter. R Squared Ltd purchased a new position in Viemed Healthcare in the fourth quarter worth about $41,000. Finally, Barclays PLC increased its position in shares of Viemed Healthcare by 9.7% during the 4th quarter. Barclays PLC now owns 58,635 shares of the company’s stock valued at $470,000 after purchasing an additional 5,196 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Stock Performance

Shares of NASDAQ VMD opened at $6.63 on Friday. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a 12-month low of $6.21 and a 12-month high of $9.81. The firm has a market capitalization of $262.03 million, a price-to-earnings ratio of 24.56 and a beta of 1.64. The firm has a 50 day moving average of $7.33 and a 200 day moving average of $8.11.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.